Linking Your Clinical Trials to Real-World Data
Medidata Link enables clinical trial data linkage with real-world data (RWD) at the patient level to enhance evidence generation beyond what is possible in traditional clinical trials. By creating an enriched view of the patient journey before, during, and after your trial’s completion, Medidata Link generates insights that enable you to accelerate patients’ access to innovative treatments while minimizing site burden and costs.
Better Together: Clinical Trial Data to Real World Data Linkage
Enable Long-term Follow-up
Leverage trial participants’ RWD to collect data on long-term effectiveness and safety outcomes, even after trial completion, without adding burden to participants or sites. This can facilitate post-market studies, long-term effectiveness studies, and long-term safety monitoring studies.
Mitigate Loss To Follow-up
Mitigate the impact of loss to follow-up on your trial end points by monitoring participants activity through their routine care data and gaining expanded insight into their treatment and outcomes when they don’t return for scheduled follow-up.
Demonstrate Economic Value
Demonstrate economic value in payor and provider discussions by measuring the cost of care and healthcare resource utilization for trial participants before, during, and after your trial.
Medidata Link seamlessly integrates into your trial workflow to collect and ingest personally identifiable information via paper, eConsent, or Registry routes with frictionless patient or site-facing data collection tools. It is easy to implement and can reduce data collection burden on patients and study sites.
On-Demand Trial Linkage to RWD
Medidata Link gives you full flexibility in your choice of linkage approach, supporting a wide range of RWD sources and tokenization vendors. As Medidata centrally manages personally identifiable information it can also support trial linkage to RWD sources through de-identified (tokens) or identified (patient identifier) based workflows.
Compliant, Up-to-date Data
Medidata Link lets you robustly manage clinical trial data linkage consent status to meet IRB and GCP requirements, and supports consent withdrawal even after the trial concludes and sites become inaccessible.
Medidata Link provides comprehensive training materials to sites and enables seamless implementation within sites’ existing workflows for an out-of-the-box launch.
6 Data Linkage Use Cases to Future-Proof Your Clinical Trial
In this eBook, we discuss Medidata Link use cases in varied indications across the clinical development lifecycle, including:
- Tracking Patients Lost to Follow-up
- Reducing Patient Burden and Augmenting Decentralized Clinical Trials
- Monitoring and Contextualizing Patient Reported Outcomes
- Quantifying Healthcare Resource Utilization
- Evidence for Label Expansions
- Long-term Safety and Effectiveness Tracking
Watch our latest webinars on trial linkage, clinical trial tokenization, and RWD to learn how connecting clinical trial data with RWD can help create a holistic view of the patient journey.
Read our latest blogs on trial linkage, clinical trial tokenization, and RWD to learn how connecting clinical trial data with RWD can help create a holistic view of the patient journey.
myMedidata is a single-destination patient portal, built on Rave EDC, that allows patients to virtually learn, enroll and participate in clinical trial activities from any device. This offers a streamlined and trusted approach to virtualizing clinical trials. myMedidata encompasses all of the capabilities of Medidata’s patient-facing solutions for electronic consent and clinical outcomes assessment (eCOA) along with live video investigator/patient visits using myMedidata LIVE all through one web-based intuitive interface.
Medidata’s eConsent is an innovative, regulatory-compliant, patient-friendly, electronic consent system for clinical trials. Whether onsite or remote, Medidata eConsent automates the patient enrollment process and onboards patients directly into Rave EDC, improving overall consent tracking management, reducing informed consent errors, and easing the administrative burden for sites and study teams. It also enhances the patient experience with easy-to-understand clinical trial information while improving participant compliance and boosting patient engagement.
The life science industry frequently uses patient centricity as a buzzword, but promoting the idea of patient centricity without action dilutes the term’s meaning and frustrates patients. myMedidata’s Patient Insights is the process by which the patient perspective is infused into the software development life cycle to create technical solutions that improve the overall patient experience in clinical research operations.